Aska Pharmaceutical partners with Red Arrow Therapeutics on new preeclampsia treatment

March 19, 2024

Aska Pharmaceutical Co. Ltd., a subsidiary of Aska Pharmaceutical Holdings Co. Ltd., and Red Arrow Therapeutics Inc. have signed a joint research agreement to develop a new treatment for preeclampsia using advanced nanotechnology.

BioWorld Science Nanotechnology Gynecology/obstetrics Women's health

Today's news in brief

BioWorld

BioWorld briefs for July 22, 2025.

Coinfections and diversity paint the many shades of HIV cure

BioWorld

We all look different to HIV, a virus that destroys the immune system. The defensive cells record every interaction with foreign agents, infections from viruses...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 22, 2025.

Livzon’s IL-17A/F meets phase III endpoints in plaque psoriasis

BioWorld

Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted...

Sino to acquire Lanova and pipeline for up to $950M

BioWorld Asia

Sino Biopharmaceutical Ltd. agreed to fully acquire Lanova Medicines Ltd. by buying an additional 95.09% stake in Lanova at a valuation of up to $950.92 million....